National Vision Launches its First-Ever Philanthropic Impact Report
DULUTH, Ga., Aug. 12, 2020 (GLOBE NEWSWIRE) — National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”), one […]
Rackspace Technology Global Announces Tender Offer for Up to $600.0 million of its 8.625% Senior Notes due 2024
SAN ANTONIO, Aug. 12, 2020 (GLOBE NEWSWIRE) — Rackspace Technology Global, Inc. (NASDAQ:RXT) (the “Company”) today announced that it is […]
Equillium Reports Second Quarter 2020 Financial Results and Recent Highlights
LA JOLLA, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to […]
Gulf Resources Announces Conference Call to Discuss Second Quarter 2020 Results
SHOUGUANG, China, Aug. 12, 2020 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (Nasdaq:GURE) (“Gulf Resources” or the “Company”), a leading manufacturer […]
TAOP Released 43-inch and 55-inch Smart Screens for More Life Scenes
SHENZHEN, China, Aug. 12, 2020 (GLOBE NEWSWIRE) — Taoping Inc. (NASDAQ: TAOP, the “Company”), a leading provider of internet-based smart […]
Monopar Announces Plan to Advance Development of Novel Triage Test for Severe COVID-19 Utilizing its Patented Technology
WILMETTE, Ill., Aug. 12, 2020 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR) today announced its plan to develop a […]
Wilhelmina International, Inc. Reports Results for Second Quarter 2020
Second Quarter Financial ResultsDALLAS, Aug. 12, 2020 (GLOBE NEWSWIRE) — Wilhelmina International, Inc. (Nasdaq:WHLM) (“Wilhelmina” or the “Company”) today reported [...]
Atreca Reports Second Quarter 2020 Financial Results and Recent Corporate Developments
SOUTH SAN FRANCISCO, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused […]
Eton Pharmaceuticals Announces Second Quarter 2020 Financial Results
DEER PARK, Ill., Aug. 12, 2020 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on […]
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests
IRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) announced today that the United States Patent and […]
